# CLONEVO (NCT03837821)

> (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03837821
- Phase: EARLY_PHASE1
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Weill Medical College of Cornell University
- Conditions: Bladder Cancer
- Interventions: Abemaciclib
- Enrollment: 20
- Primary outcome: Change in cell-cycle dynamics between pre- and post-Abemaciclib tumor samples

## Commentary we found

- X threads: 18
- YouTube: 2
- Podcasts: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=clonevo-nct03837821

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03837821", "email": "<work email>"}; the inbox owner confirms by the emailed link.